Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK
News
Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
Accounting for 4% of all cases, kidney cancer is currently the sixth most common cancer diagnosed in the UK
Serac’s imaging agent marks a breakthrough in endometriosis detection
Early-stage endometriosis now visible through non-invasive imaging
Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment
Phase 2 trial reveals significant improvement in MASH patients
Amgen’s trial brings new hope for IgG4-RD patients
Inebilizumab shows sound efficacy in landmark research
Alchemab receives funding boost for Parkinson’s research
Innovative antibody discovery could lead to new Parkinson’s treatments
Sanofi’s Sarclisa shows significant promise in treating myeloma
Phase 3 research suggests a significant leap forward in myeloma management
Resolution unveils data for liver disease treatment at EASL 2024
Extended phase 2 study highlights macrophage cell therapy’s efficacy
EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment
Collaboration yields promising Barriolide therapy Enterothelin
invoX Pharma’s FS222 delivers encouraging solid tumour treatment results
Positive clinical data from phase 1 study presented at ASCO annual meeting
New UCL-developed immunotherapy shows promising results in treating bone cancer
Bone cancer affects more than 150,000 people in the UK and is often resistant to chemotherapy
International KCL research project to develop SMARTdrugs for aggressive cancers
The platform will be used to diagnose and treat cancers, including lung and brain tumours
The Crick announces new partnerships with SMEs and MRC for research
The projects will focus on a range of research areas, including Down’s syndrome and ALS
NHS platform announced to accelerate personalised cancer vaccine clinical trials
The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines
NHS hospitals to roll out ‘Martha’s Rule’ as part of patient safety initiative
The first phase of the programme will be in place in hospitals across the UK by March 2025
